List of ProteoTech patents

Patents where

Current Assignee

Name

‌

ProteoTech

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7763747 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease	Patent 7763747 was granted and assigned to ProteoTech on July, 2010 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7763747	July 27, 2010
‌ US Patent 7601876 Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis	Patent 7601876 was granted and assigned to ProteoTech on October, 2009 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7601876	October 13, 2009
‌ US Patent 7754250 Composition and methods for treating Alzheimer's disease and other amyloidoses	Patent 7754250 was granted and assigned to ProteoTech on July, 2010 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7754250	July 13, 2010
‌ US Patent 7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease	Patent 7514583 was granted and assigned to ProteoTech on April, 2009 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7514583	April 7, 2009
‌ US Patent 8003612 Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein disorders	Patent 8003612 was granted and assigned to ProteoTech on August, 2011 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8003612	August 23, 2011
‌ US Patent 9051253 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's	Patent 9051253 was granted and assigned to ProteoTech on June, 2015 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	9051253	June 9, 2015
‌ US Patent 7759311 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders	Patent 7759311 was granted and assigned to ProteoTech on July, 2010 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7759311	July 20, 2010
‌ US Patent 7714170 Use of compounds and compositions for the treatment of amyloid diseases	Patent 7714170 was granted and assigned to ProteoTech on May, 2010 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7714170	May 11, 2010
‌ US Patent 8455687 Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies	Patent 8455687 was granted and assigned to ProteoTech on June, 2013 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8455687	June 4, 2013
‌ US Patent 8227643 Sirtuin 1 and the treatment of neurodegenerative diseases	Patent 8227643 was granted and assigned to ProteoTech on July, 2012 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8227643	July 24, 2012
‌ US Patent 9085549 Compounds for the treatment of neurodegenerative diseases	Patent 9085549 was granted and assigned to ProteoTech on July, 2015 by the United States Patent and Trademark Office.	‌ ProteoTech	‌ ProteoTech	United States Patent and Trademark Office	9085549	July 21, 2015
‌ US Patent 8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease	Patent 8895554 was granted and assigned to ProteoTech on November, 2014 by the United States Patent and Trademark Office.	‌ ProteoTech	‌ ProteoTech	United States Patent and Trademark Office	8895554	November 25, 2014
‌ US Patent 7723057 Screening assay for macromolecules that inhibit binding of sulfated glycosaminoglycan to beta amyloid	Patent 7723057 was granted and assigned to ProteoTech on May, 2010 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7723057	May 25, 2010
‌ US Patent 7919530 Compounds, compositions, and methods for the treatment of synucleinopathies	Patent 7919530 was granted and assigned to ProteoTech on April, 2011 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7919530	April 5, 2011
‌ US Patent 8865754 Compounds for the treatment of neurodegenerative diseases	Patent 8865754 was granted and assigned to ProteoTech on October, 2014 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8865754	October 21, 2014
‌ US Patent 8956818 Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases	Patent 8956818 was granted and assigned to ProteoTech on February, 2015 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8956818	February 17, 2015
‌ US Patent 8829198 Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies	Patent 8829198 was granted and assigned to ProteoTech on September, 2014 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8829198	September 9, 2014
‌ US Patent 8916598 Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies	Patent 8916598 was granted and assigned to ProteoTech on December, 2014 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8916598	December 23, 2014
‌ US Patent 9133176 Isolation, purification and synthesis of procyanidin B2 and uses thereof	Patent 9133176 was granted and assigned to ProteoTech on September, 2015 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	9133176	September 15, 2015
‌ US Patent 7745490 Substituted N-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies	Patent 7745490 was granted and assigned to ProteoTech on June, 2010 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7745490	June 29, 2010
‌ US Patent 7205008 Methods of treating Alzheimer's disease and other amyloidoses using	Patent 7205008 was granted and assigned to ProteoTech on April, 2007 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	7205008	April 17, 2007
‌ US Patent 8754133 Compounds, compositions and methods for the treatment of inflammatory diseases	Patent 8754133 was granted and assigned to ProteoTech on June, 2014 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8754133	June 17, 2014
‌ US Patent 8163957 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease	Patent 8163957 was granted and assigned to ProteoTech on April, 2012 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8163957	April 24, 2012
‌ US Patent 8592476 Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies	Patent 8592476 was granted and assigned to ProteoTech on November, 2013 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8592476	November 26, 2013
‌ US Patent 8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease	Patent 8586585 was granted and assigned to ProteoTech on November, 2013 by the United States Patent and Trademark Office.		‌ ProteoTech	United States Patent and Trademark Office	8586585	November 19, 2013

Results per page:

26 results

0 selected

26 results

0 selected